Sensus Healthcare (SRTS) Common Equity (2015 - 2026)

Sensus Healthcare has reported Common Equity for 12 years, with the latest figure at $45.5 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 14.13% year-over-year to $45.5 million; the trailing twelve-month figure through Mar 2026 stood at $45.5 million (down 14.13% YoY), and the FY2025 full-year result was $48.1 million, down 13.84% from the prior year.
• Common Equity for Q1 2026 stood at $45.5 million, down from $48.1 million in the prior quarter.
• The five-year high for Common Equity was $55.8 million in Q4 2024, with the low at $42.5 million in Q1 2022.
• Average Common Equity over 5 years is $49.0 million, with a median of $48.1 million recorded in 2025.
• Year-over-year, Common Equity surged 128.68% in 2022 and retreated 14.13% in 2026.
• Tracing SRTS's Common Equity over 5 years: stood at $48.1 million in 2022, then climbed by 1.61% to $48.8 million in 2023, then climbed by 14.3% to $55.8 million in 2024, then retreated by 13.84% to $48.1 million in 2025, then fell by 5.31% to $45.5 million in 2026.
• The last three Common Equity figures came in at $45.5 million (Q1 2026), $48.1 million (Q4 2025), and $51.2 million (Q3 2025), per Business Quant data.

Peer Comparison